G.F.C Green Fields Capital Valuation
Is GFC-M undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
4/6Valuation Score 4/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of GFC-M when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: GFC-M (₪12.22) is trading below our estimate of fair value (₪21.25)
Significantly Below Fair Value: GFC-M is trading below fair value by more than 20%.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for GFC-M?
Other financial metrics that can be useful for relative valuation.
What is GFC-M's n/a Ratio? | |
---|---|
n/a | 0x |
n/a | n/a |
Market Cap | ₪122.67m |
Key Statistics | |
---|---|
Enterprise Value/Revenue | n/a |
Enterprise Value/EBITDA | n/a |
PEG Ratio | n/a |
Price to Earnings Ratio vs Peers
How does GFC-M's PE Ratio compare to its peers?
Company | Forward PE | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 20.8x | ||
KMDA Kamada | 36.7x | 29.3% | ₪1.1b |
INCR InterCure | 25.1x | n/a | ₪524.1m |
MBX Microbix Biosystems | 12.6x | n/a | CA$47.4m |
IBT IBEX Technologies | 8.9x | n/a | CA$35.3m |
GFC-M G.F.C Green Fields Capital | 7.8x | n/a | ₪122.7m |
Price-To-Earnings vs Peers: GFC-M is good value based on its Price-To-Earnings Ratio (7.8x) compared to the peer average (20.8x).
Price to Earnings Ratio vs Industry
How does GFC-M's PE Ratio compare vs other companies in the Asian Biotechs Industry?
Price-To-Earnings vs Industry: GFC-M is good value based on its Price-To-Earnings Ratio (7.8x) compared to the Asian Biotechs industry average (33.6x).
Price to Earnings Ratio vs Fair Ratio
What is GFC-M's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PE Ratio | 7.8x |
Fair PE Ratio | n/a |
Price-To-Earnings vs Fair Ratio: Insufficient data to calculate GFC-M's Price-To-Earnings Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.